Identification
Personal identification
- Full name
- Marta Reina Couto
Citation names
- Couto, Marta
- Reina-Couto, M.
- Couto, MR
Author identifiers
- Ciência ID
- 6110-28F7-1E5D
Email addresses
- martafrcouto@hotmail.com (Personal)
Knowledge fields
- Medical and Health Sciences - Basic Medicine - Pharmacology and pharmacy
- Medical and Health Sciences - Clinical Medicine - Critical care Medicine and Emergency Medicine
- Medical and Health Sciences - Clinical Medicine - Cardiac and Cardiovascular Systems
- Medical and Health Sciences - Clinical Medicine - General and Internal Medicine
- Medical and Health Sciences - Clinical Medicine - Other Clinical Medicine Subjects
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
Portuguese (Mother tongue) | |||||
English | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) |
Spanish; Castilian | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) |
French | Elementary (A2) | Elementary (A2) | Elementary (A2) | Elementary (A2) | Elementary (A2) |
German | Beginner (A1) | Beginner (A1) | Beginner (A1) | Beginner (A1) | Beginner (A1) |
Education
Degree | Classification | |
---|---|---|
2022/05 - 2025
Ongoing
|
Grau de Consultor da Especialidade de Medicina Interna (Título de especialista)
Hospital São Pedro de Vila Real, Portugal
|
|
2023/01 - 2023/06
Attended
|
Economia da Saúde e Resultados em Saúde (Pós-Graduação)
Universidade Nova de Lisboa Escola Nacional de Saúde Pública, Portugal
|
|
2016/01 - 2022
Ongoing
|
Farmacologia e Toxicologia Experimentais e Clínicas (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
|
|
2018 - 2021
Concluded
|
Medicina Intensiva (Título de especialista)
Centro Hospitalar Universitário de São João, Portugal
|
|
2017 - 2017
Concluded
|
Farmacologia Clínica (Título de especialista)
Universidade do Porto Faculdade de Medicina, Portugal
|
|
2015 - 2015
Concluded
|
Farmacologia e Toxicologia Experimentais e Clínicas (Curso de doutoramento (conclusão de unidades curriculares))
Universidade do Porto Faculdade de Medicina, Portugal
|
17,5 |
2009/01/01 - 2013/12/31
Concluded
|
Medicina Interna (Título de especialista)
Centro Hospitalar Universitário de São João Serviço Medicina Interna, Portugal
|
19,9 |
2008/01 - 2008/12
Concluded
|
Internato do Ano Comum (Especialização pós-licenciatura)
Major in Formação generalista de Medicina
Centro Hospitalar Universitário de São João, Portugal
|
Aprovado |
1999/09/01 - 2007/07/01
Concluded
|
Medicina (Licenciatura)
Universidade do Porto Faculdade de Medicina, Portugal
|
16 |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2005/03 - 2015 | Researcher (Research) | Universidade do Porto Faculdade de Medicina, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2010/09 - Current | Invited Assistant (University Teacher) | Universidade do Porto Faculdade de Medicina, Portugal |
Universidade do Porto Faculdade de Medicina, Portugal |
Other Careers
Category Host institution |
Employer | |
---|---|---|
2014 - Current | Assistente (Médica) | Centro Hospitalar Universitário de São João, Portugal |
Centro Hospitalar Universitário de São João, Portugal | ||
2008/01 - 2013/12 | Interno (Médica) | Centro Hospitalar Universitário de São João Serviço Medicina Interna, Portugal |
Centro Hospitalar Universitário de São João Serviço Medicina Interna, Portugal |
Positions / Appointments
Category Host institution |
Employer | |
---|---|---|
2020 - 2024 | Membro da Direção do Colégio de Especialidade de Farmacologia Clínica | Ordem dos Médicos, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2023 - Current | Membro da Comissão de Farmácia e Terapêutica | Unidade Local de Saúde São João, Portugal |
Projects
Contract
Designation | Funders | |
---|---|---|
2018/07 - Current | Resolution of inflammation: a missing key to improve acute heart failure treatment and prognosis?
PTDC/MEC-CAR/32188/2017
POCI-01-0145-FEDER- 032188
Researcher
Universidade do Porto Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2020/07 - 2021/07 | Unresolved inflammation and endothelitis in severe COVID-19 patients: identification of risk stratification biomarkers and
therapeutic targets
613690173
Researcher
Universidade do Porto Faculdade de Medicina, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2009 - 2010 | Evaluation of intrarenal renin-angiotensin system activation and oxidative stress in chronic heart failure.
PP-IJUP2009-119
Supervisor
Universidade do Porto Faculdade de Medicina, Portugal
|
Banco Santander Portugal
Concluded
|
Outputs
Publications
Book chapter |
|
Conference abstract |
|
Conference poster |
|
Journal article |
|
Newsletter article |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2022 | ACE2/ACE balance in COVID-19 patients with different disease severity. | LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
(Porto, Portugal)
|
2022 | Inflammatory cytokine response in moderate and severe COVID-19 patients and its relationship to prognosis. | LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
(Porto, Portugal)
|
2022 | Arachidonic acid derived proresolving or proinflammatory mediators and lipoxin receptor expression in human acute heart failure and cardiogenic shock | LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
(Porto, Portugal)
|
2022 | Impact of previous ß-blocker treatment on inflammatory status of acute heart failure and cardiogenic shock patients. | LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
(Porto, Portugal)
|
2021 | Comparison of endothelial activation profiles in critically ill patients with cardiogenic shock, septic shock and severe COVID-19. | 8th European Virtual Congress of Pharmacology (EPHAR 2021), 2021
(Czech Republic)
|
2021 | Inflammatory and resolution of inflammation responses in critically ill patients with cardiogenic shock, septic shock and severe COVID-19. | 8th European Virtual Congress of Pharmacology (EPHAR 2021), 2021
(Czech Republic)
|
2021 | Evaluation of serum and urinary lipoxin profiles and FPR2/ALX receptor expression in human acute heart failure, cardiogenic shock and septic shock. | 8th European Virtual Congress of Pharmacology (EPHAR 2021), 2021
(Czech Republic)
|
2021 | Urinary biomarkers of oxidative stress, inflammation and vascular dysfunction in septic shock patients and their relationship with organ dysfunction and prognosis. | LI Reunião da Sociedade Portuguesa de Farmacologia
Universidade de Lisboa Faculdade de Farmácia (Lisboa, Portugal)
|
2021 | Endothelial cell activation and proinflammatory status decrease during hospitalization in septic shock but not in cardiogenic shock. | LI Reunião da Sociedade Portuguesa de Farmacologia
Universidade de Lisboa Faculdade de Farmácia (Lisboa, Portugal)
|
2021 | Resolution of inflammation in human acute heart failure and cardiogenic shock: role of resolvin D1 and E1. | LI Reunião da Sociedade Portuguesa de Farmacologia
Universidade de Lisboa Faculdade de Farmácia (Lisboa, Portugal)
|
2020 | Lipoxin profiles in human acute heart failure and cardiogenic shock and their modulation by aspirin or statin therapy. | ESCI Virtual - COVID Edition 2020 |
2020 | Proinflammatory cytokines and endothelial cell activation in human acute heart failure and cardiogenic shock. | ESCI Virtual - COVID Edition 2020 |
2020 | Serum and urinary lipoxins profiles in patients with acute heart failure and cardiogenic shock. | L Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
|
2020 | Comparison of the inflammatory profile in patients with cardiogenic shock or septic shock. | L Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal) (Coimbra, Portugal)
|
2019 | Endocan, a novel endothelial dysfunction biomarker, is associated with ventricular dysfunction, inflammation and worse hemodynamics in human acute heart failure. | YES Meeting 2019
Universidade do Porto Faculdade de Medicina (Porto, Portugal) (Porto, Portugal)
|
2019 | Endothelial dysfunction and inflammation resolving mediators in human acute heart failure. | XLIX Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal) (Porto, Portugal)
|
2019 | Specialized proresolving mediators (SPMs) in human acute heart failure (AHF). | 1a Reunião do Programa Doutoral em Farmacologia e Toxicologia Experimental e Clínica
Universidade do Porto Faculdade de Medicina (Porto, Portugal) (Porto, Portugal)
|
2018 | Endocan and resolvin D1: two novel biomarkers for the management of acute heart failure? | 31st Annual Congress of the European Society of Intensive Care Medicine – ESICM LIVES 2018
European Society of Intensive Care Medicine (Paris, France)
|
2013 | Anti-inflammatory lipoxins in patients with chronic heart failure and their modulation by low-dose acetylsalicylic acid. | 47th Annual Scientific Meeting of the European Society for Clinical Investigation
European Society for Clinical Investigation (Albufeira, Portugal) (Albufeira, Portugal)
|
2013 | Anti-inflammatory lipid mediators in cardiovascular diseases: impact of aspirin. | Seminários FMUP
Universidade do Porto Faculdade de Medicina (Porto, Portugal) (Porto, Portugal)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2021/09 - Current | Evolution of endocan and other endothelial dysfunction markers in COVID-19 patients with different stages of disease severity.
Co-supervisor of David André Rosário Alves
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2021/09 - Current | Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients.
Co-supervisor of Mariana Simões de Carvalho Roboredo Madeira
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2021/09 - Current | Evaluation of urinary 11- dehydrothromboxane B2 as a biomarker of severity and putative therapeutic target in human acute
heart failure.
Co-supervisor of Ana Isabel Sousa Oliveira
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020/09 - 2021/06/22 | Urinary cysteinyl leukotrienes as biomarkers of endothelial activation, inflammation and oxidative stress and their relationship
with organ dysfunction in human septic shock.
Supervisor of Marisa Oliveira Santos
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2020/09 - 2021/05/28 | Renal renin-angiotensin system activation in acute heart failure and its association with endothelial dysfunction, inflammation
and oxidative stress.
Co-supervisor of Álvaro Alexandre Ferreira Duarte
|
Medicina
Universidade do Porto Faculdade de Medicina, Portugal
|
2019/08 - 2020/08 | Endocan: a novel biomarker for risk stratification, prognosis, and therapeutic monitoring in human cardiovascular and renal
diseases.
Co-supervisor of João Pedro Peixoto de Bessa e Silva
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2016 - 2017 | Aspirin and blood pressure: effects when used alone or in combination with antihypertensive drugs.
Co-supervisor of Ana Catarina Gonçalves da Costa
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2014 - 2015 | Statins and oxidative stress in chronic heart failure.
Co-supervisor of Sónia Cristina Torres da Costa
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2013 - 2014 | Resolution of inflammation in heart failure: novel lipid mediators.
Co-supervisor of Luís Manuel Pedrosa do Vale
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2011 - 2012 | Evaluation of lipoxins in heart failure.
Co-supervisor
|
Bioquímica (Master)
Universidade do Porto Faculdade de Ciências, Portugal
|
2011 - 2012 | Oxidative stress in heart failure: therapeutic implications.
Co-supervisor of Marco Frederico Oliveira Marques
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2011 - 2012 | Renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients
Co-supervisor
|
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2019/12/05 | Estrategias de tratamientodel paciente co insuficiencia cardiacasistólica agudamente descompensada: efectos de frecuentes
doses de furosemide sobre los niveles serios de urea y cobre el cociente urea/creatinina
Thesis Member
|
Rafael Ramion Villegas Mendez (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
Association member
Society Organization name | Role | |
---|---|---|
2018 - Current | European Society of Intensive Care Medicine | Membro |
2012 - Current | Sociedade Portuguesa de Farmacologia | Efective member |
Committee member
Activity description Role |
Institution / Organization | |
---|---|---|
2022 - Current | Colégio de Medicina Intensiva
Member
|
Ordem dos Médicos, Portugal |
2020 - Current | Membro da Direcção do Colégio de Farmacologia Clínica da Ordem dos Médicos
Other
|
Ordem dos Médicos, Portugal |
2014 - Current | Colégio de Medicina Interna
Member
|
Ordem dos Médicos, Portugal |
Consulting
Activity description | Institution / Organization | |
---|---|---|
2021 - Current | Membro da comissão de trabalho na DGS para norma terapêutica do tratamento da COVID-19 no âmbito de membro do Colégio de Farmacologia Clínica da Ordem dos Médicos | Centro Hospitalar Universitário de São João, Portugal |
2019 - Current | Cerca de 50 pareceres/ano para Comissão de Farmácia e Terapêutica do CHUSJ no âmbito de membro da Unidade de Farmacologia Clínica | Centro Hospitalar Universitário de São João, Portugal |
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2010 - Current | Farmacologia | Medicina (Mestrado integrado) | Universidade do Porto Faculdade de Medicina, Portugal |
2010 - Current | Terapêutica | Medicina (Mestrado integrado) | Universidade do Porto Faculdade de Medicina, Portugal |
Distinctions
Award
2024 | Ambiotis poster prize |
2020 | ESCI Short Presentation Award - European Society of Clinical Investigation, Netherlands
European Society for Clinical Investigation, Netherlands
|
2019 | 3rd Prize - Oral Presentation - Plenary Session YES Meeting 2019
Universidade do Porto Faculdade de Medicina, Portugal
|
2013 | Alberto Ferrari Poster Prize - European Society of Hypertension, Italy |
2012 | 1st place poster prize National Congress of HIV |
2010 | 3rd place in Hypertension Summer School |